Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging
Clinical trial NCT04946383 · UNKNOWN
Trial details
- NCT number
- NCT04946383
- Sponsor
- TruDiagnostic
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2021-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.